Delivery Order SPE2DB22D1106-SPE2DB25FEDK9

Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication Mounjaro 5 mg/0.5 ml pen, with a total ceiling value of $5,226.89 and a period of performance through November 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,447.12, is a delivery order to supply the medication Mounjaro (5 mg/0.5 ml pen) for the DLA. The contract has a ceiling value of $5,447.12 and a period of performance through February 28, 2025. The contract is a firm fixed-price type and does not have a set-aside designation, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro, a 5 mg/0.5 ml medication pen. The award has a ceiling value of $2,448.81 and a performance period ending on May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,620.34, is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, for the delivery of Mounjaro 5 mg/0.5 ml pens. The contract has a firm fixed price of $3,156.00 and a period of performance through March 19, 2024. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Mounjaro 5 mg/0.5 ml pen. The award, valued at $3,156.00, is a firm fixed-price contract with an ultimate completion date of August 7, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, worth up to $999,999,999 through December 2025,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,132.44 and a completion date of January 15, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $2,367.00 and a completion date of November 19, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Mounjaro 5 mg/0.5 mL pens. The contract has a ceiling value of $6,695.48 and a completion date of May 23, 2024. It is a firm-fixed-price contract type. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 7.5 mg/0.5 ml pens. The contract is a Delivery Order with a Firm Fixed Price of $1,632.54 and has an ultimate completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEDK9
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of the drug Mounjaro 5 mg/0.5 ml pen, with a total ceiling value of $2,720.90 and a performance period ending on March 18, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 6/16/25, 10:56 AM